Detalles de la búsqueda
1.
Efficacy and survival of nivolumab treatment for recurrent/unresectable esophageal squamous-cell carcinoma: real-world clinical data from a large multi-institutional cohort.
Esophagus;
21(3): 319-327, 2024 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-38717686
2.
Tumor Response Predicts Survival Time of Nivolumab Monotherapy for Advanced Gastric Cancer: A Subgroup Analysis of the DELIVER Trial (JACCRO GC-08).
Oncologist;
2024 Apr 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38581687
3.
Serum NY-ESO-1 antibody as a predictive biomarker for postoperative recurrence of gastric cancer: a multicenter prospective observational study.
Br J Cancer;
130(7): 1157-1165, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38326601
4.
Effects of postoperative oral elemental nutritional supplement on skeletal muscle loss after gastrectomy for gastric cancer.
Int J Clin Oncol;
29(3): 266-275, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38227091
5.
Phase II study of S-1 plus docetaxel as first-line treatment for older patients with advanced gastric cancer (OGSG 0902).
Int J Clin Oncol;
29(2): 134-141, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38227090
6.
Clinical Significance of Increased Skeletal Muscle Mass During Nab-Paclitaxel Plus Gemcitabine Treatment in Patients With Advanced Pancreatic Cancer.
Pancreas;
53(1): e22-e26, 2024 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38157455
7.
Effect of the number of cycles of docetaxel + S-1 therapy on long-term survival in adjuvant chemotherapy for stage III gastric cancer. A pooled analysis of the OGSG0604 and OGSG1002 trials.
Gastric Cancer;
26(5): 788-797, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37335367
8.
Soluble programmed cell death ligand 1 predicts prognosis for gastric cancer patients treated with nivolumab: Blood-based biomarker analysis for the DELIVER trial.
Eur J Cancer;
184: 10-20, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36889037
9.
[A Case of Laparoscopic Uterine and Vaginal Resection for Local Recurrence after Abdominoperineal Resection for Anal Canal Cancer].
Gan To Kagaku Ryoho;
50(3): 354-356, 2023 Mar.
Artículo
en Japonés
| MEDLINE | ID: mdl-36927907
10.
Do antihypertensive drugs really have antitumor effects? Baseline differences in hypertensive and non-hypertensive patients with advanced pancreatic cancer.
Medicine (Baltimore);
101(29): e29532, 2022 Jul 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-35866833
11.
A phase II study of S-1 therapy for patients with advanced and recurrent esophageal cancer resistant or intolerable to fluorouracil, platinum, and taxane therapy (OGSG 1404).
Esophagus;
19(4): 711-716, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35723843
12.
Baseline Factors Predictive of the Receipt of Second-Line Chemotherapy After Nab-Paclitaxel Plus Gemcitabine for Patients With Advanced Pancreatic Cancer.
Pancreas;
51(3): 278-281, 2022 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35584386
13.
Real-world effectiveness of third- or later-line treatment in Japanese patients with HER2-positive, unresectable, recurrent or metastatic gastric cancer: a retrospective observational study.
Int J Clin Oncol;
27(7): 1154-1163, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35489010
14.
[A Case of Robotic-Assisted Total Pelvic Exenteration for Locally Advanced Rectal Cancer Invading the Prostate].
Gan To Kagaku Ryoho;
49(4): 453-455, 2022 Apr.
Artículo
en Japonés
| MEDLINE | ID: mdl-35444133
15.
[A Case of Laparoscopic Total Pelvic Exenteration for Sigmoid Colon Cancer Using Infrared Illumination System (IRIS)].
Gan To Kagaku Ryoho;
49(4): 456-458, 2022 Apr.
Artículo
en Japonés
| MEDLINE | ID: mdl-35444134
16.
Three-Year Outcomes of a Phase II Study of Perioperative Capecitabine Plus Oxaliplatin Therapy for Clinical SS/SE N1-3 M0 Gastric Cancer (OGSG 1601).
Oncologist;
27(4): 251-e304, 2022 04 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35380725
17.
Optimal Relative Dose Intensity in the First 4 Weeks During Nab-Paclitaxel Plus Gemcitabine for Older Patients With Advanced Pancreatic Cancer in Japan.
Pancreas;
51(1): e4-e6, 2022 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35195606
18.
Real-world effectiveness of nivolumab in advanced gastric cancer: the DELIVER trial (JACCRO GC-08).
Gastric Cancer;
25(1): 235-244, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34427838
19.
[A Case of Early Appendiceal Adenocarcinoma Coexisting with High-Grade Appendiceal Mucinous Neoplasm].
Gan To Kagaku Ryoho;
49(13): 1714-1716, 2022 Dec.
Artículo
en Japonés
| MEDLINE | ID: mdl-36733186
20.
Effects of an oral elemental nutritional supplement in gastric cancer patients with adjuvant S-1 chemotherapy after gastrectomy: A multicenter, open-label, single-arm, prospective phase II study (OGSG1108).
Ann Gastroenterol Surg;
5(6): 776-784, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34755009